epigenetics Aug 5, 2022 Chronic Lymphocytic Leukemia Genomic Study Reveals New Subtypes, Ties to Outcomes Mar 31, 2022 New Esophageal Cancer Tests on Horizon as Hopkins Spinout Capsulomics Preps Clinical Launch Premium Jan 7, 2022 Banner Year for Blood-Based Cancer Screening in 2021, but Reimbursement and Utility Hurdles Loom Premium Aug 31, 2021 Oxford BioDynamics Awarded Grant to Apply EpiSwitch to ICI Cancer Therapy Response Jun 18, 2021 Dartmouth Spinoff Episteme Prognostics Aims to Bring Precision Epigenetics to Pancreatic Cancer Premium Jun 16, 2021 Mnemo Therapeutics Raises $90M in Series A Funding Round Apr 15, 2021 Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches Premium Mar 31, 2021 Delfi Diagnostics Starts Prospective Lung Cancer Screening Trial Jan 11, 2021 Multi-Cancer Molecular Screening Assays Primed for Clinical Implementation in 2021 Premium Sep 15, 2020 Pancreatic Cancer Treatment Clues Uncovered From Genomic, Chromatin Profiles Jul 1, 2020 AnchorDx Demonstrates Liquid Biopsy DNA Methylation Test for Early Cancer Detection Premium Apr 30, 2020 Washington University, BostonGene Expand Kidney Cancer Research Collaboration Jun 3, 2019 Grail's Newest Early Cancer Detection Data Lays Path for Return of Results Next Year Premium Jan 24, 2019 Noninvasive Prostate Cancer MDx Test Enters Validation Phase After Initial Results Published in JCO Premium Breaking News Apollomics Completes SPAC Merger, Begins Public Trading on Nasdaq Ablaze Pharmaceuticals to Develop RayzeBio's GPC3-Targeted Radiotherapy In Brief This Week: Allarity Therapeutics, Immutep, Thermo Fisher Scientific EMA's CHMP Recommends BMS's Breyanzi as Second-Line Lymphoma Treatment Exai Bio, Quantum Leap Healthcare Collaborative Expand Participation in RNA Liquid Biopsy Trial Omega Therapeutics, Roche Partner for Phase I/II Trial in MYC-Driven Hepatocellular Carcinoma
